Market revenue in 2023 | USD 4.1 million |
Market revenue in 2030 | USD 5.3 million |
Growth rate | 3.7% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.78% in 2023. Horizon Databook has segmented the Denmark in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
The use of validated diagnostic tests is crucial for success in the market. The Denmark IVD quality control market is driven by various factors, such as the presence of a well-established healthcare infrastructure, a high disease burden, and a growing demand for diagnostic tests.
According to Healthcare Denmark, one in every three people in Denmark over the age of 16 suffers from at least one chronic disease, which propels the need for systemic preventive efforts such as early detection and efficient disease management.
Moreover, according to the World Cancer Research Fund International, the cancer rate is highest in Denmark in the world, which is 334.9 cases per 100,000 population. Such variables lead to an increase in demand for quality control of IVD tests for early diagnosis of diseases.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into Denmark in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account